Results 91 to 100 of about 528,622 (127)

Cytosorb® haemoadsorption: a potential game changer for patients needing myocardial surgical revascularisation

open access: yes, 2022
Cytosorb, an extracorporeal blood purification system, utilises the principles of haemoadsorption to remove low molecular weight substances from the blood, including multiple cytokines such as interleukin (IL)-1b, IL-6, IL-8, and tumour necrosis factor-α,
Raja, Shahzad G.   +6 more
core  

International registry on the use of the CytoSorb® adsorber in ICU patients

open access: yes, 2017
INTRODUCTION: The aim of this clinical registry is to record the use of CytoSorb(R) adsorber device in critically ill patients under real-life conditions. METHODS: The registry records all relevant information in the course of product use, e.
Z. Molnar   +52 more
core   +1 more source

Does adjunctive hemoadsorption provide benefit in the management of ischemia–reperfusion syndrome following near-drowning? A case report

open access: yesFrontiers in Medicine
Drowning remains a significant global health concern, claiming over 300,000 lives annually, with a disproportionate impact on young individuals in low-and middle-income countries.
Pedja Kovacevic   +13 more
doaj   +1 more source

2025 ACVIM Forum Research Abstract Program

open access: yes
Journal of Veterinary Internal Medicine, Volume 39, Issue 6, November/December 2025.
wiley   +1 more source

Novel use of Cytosorb™ haemadsorption to provide biochemical control in liver impairment

open access: yes, 2018
We describe the use of Cytosorb™, a synthetic extracorporeal haemoperfusion adsorption column, in the management of two patients with drug induced cholestasis and a third with alcoholic hepatitis and subsequent acute on chronic liver failure.
VD Dhokia   +3 more
core   +1 more source

The effect of cytosorb® application on kidney recovery in critically ill patients with severe rhabdomyolysis: a propensity score matching analysis. [PDF]

open access: yesRen Fail, 2023
Gräfe C   +9 more
europepmc   +1 more source

The cytokine adsorber Cytosorb® does not reduce ammonia concentrations in critically ill patients with liver failure. [PDF]

open access: yesIntensive Care Med, 2023
Liebchen U   +5 more
europepmc   +1 more source

Impact of different extracorporeal blood purification strategies during continuous renal replacement therapy in septic shock patients

open access: yes
Background: Septic shock with acute kidney injury is associated with high mortality. Hemoadsorption methods such as CytoSorb® in conjunction with standard continuous renal replacement therapy (CRRT) and oXiris®-based CRRT are increasingly used ...
Spirić, Nikolina   +8 more
core   +1 more source

The International, Prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: Interim Results in Patients with Septic Shock. [PDF]

open access: yesAnn Intensive Care
Ferrer R   +24 more
europepmc   +1 more source

The international, prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: results from the first 300 patients. [PDF]

open access: yesJ Anesth Analg Crit Care
Ferrer R   +28 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy